Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
 

    2025  
    2024 
  
    Product Revenues – net of Discounts and Rebates 
    $163,552  
    $105,674 
  
    Cost of Revenues 
     73,272  
     65,437 
  
    Gross Profit 
     90,280  
     40,237 
  
    Research Revenues 
     92,731  
     29,631 
  
    Net Revenue 
     183,011  
     69,868 

    Operating Expenses: 

    Research and Development 
     407,622  
     337,182 
  
    General and Administrative Expenses 
     1,686,264  
     1,075,134 
  
    Total Operating Expenses 
     2,093,886  
     1,412,316 

    Loss from Operations 
     (1,910,875) 
     (1,342,448)

    Interest Expense 
     (1,790) 
     (1,402)
  
    Change in Fair Value of Derivative Liabilities 
     5,105  
     1,740,847 
  
    Other Income, net 
     30,322  
     31,051 
  
    Total Interest and Other Income, net 
     33,637  
     1,770,496 
  
    (Loss) Income from Operations before Provision for Income Taxes 
     (1,877,238) 
     428,048 
  
    Provision for Income Taxes (Note 9) 
     63  
     63 
  
    Net (Loss) Income including Noncontrolling Interest 
     (1,877,301) 
     427,985 
  
    Net Loss – Noncontrolling Interest 
     (752) 
     (2,485)
  
    Net (Loss) Income – attributed to 60 Degrees Pharmaceuticals, Inc. 
     (1,876,549) 
     430,470 

    Comprehensive (Loss) Income: 

    Net (Loss) Income 
     (1,877,301) 
     427,985 
  
    Unrealized Foreign Currency Translation Loss 
     (9,904) 
     (3,894)
  
    Total Comprehensive (Loss) Income 
     (1,887,